ENvue Medical, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -226.2% | -226.2% | -165.6% |
| FY2022 | -168.5% | -168.5% | -92.7% |
| FY2023 | -93.0% | -93.0% | -55.6% |
| FY2024 | -590.9% | -590.9% | -102.1% |
| FY2025 | -54.3% | -54.3% | -44.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -226.2% | -226.2% | -165.6% |
| FY2022 | -168.5% | -168.5% | -92.7% |
| FY2023 | -93.0% | -93.0% | -55.6% |
| FY2024 | -590.9% | -590.9% | -102.1% |
| FY2025 | -54.3% | -54.3% | -44.2% |